Albumin Market to Grow at a CAGR of 8.5% from 2025 to 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Albumin Market Size During 2025–2029?

The albumin market has demonstrated substantial growth in recent years. It is forecast to expand from $6.57 billion in 2024 to $7.16 billion in 2025, reflecting a compound annual growth rate (CAGR) of 9.0%. This historical market expansion can be linked to advancements in biotechnology, a rising need for plasma-derived therapies, broadening pharmaceutical applications, a high occurrence of liver diseases, regulatory approvals granted for albumin-based products, and the globalization of healthcare services enabling wider market access.

The albumin market is anticipated to experience substantial expansion over the upcoming years. By 2029, it is projected to reach ” $9.93 billion, growing at a compound annual growth rate (CAGR) of 8.5%. This projected growth during the forecast period is driven by factors such as the increasing prevalence of liver diseases, the expanding applications in regenerative medicine, a rising geriatric population, evolving diagnostic techniques, a shift in healthcare infrastructure towards outpatient care, and increased awareness regarding the importance of maintaining optimal protein levels. Key trends anticipated in the forecast period encompass expanding therapeutic applications, the rising adoption in drug delivery systems, an increasing demand within cell culture media, developments in personalized medicine, advancements in recombinant technology, a heightened awareness for hypoalbuminemia treatment, and substantial investment in research and development for innovative albumin-based products.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16333&type=smp

What Are The Key Drivers Of Growth In The Albumin Market?

The expanding prevalence of diabetes is anticipated to fuel the future expansion of the albumin market. Diabetes, a metabolic disorder, involves persistently elevated blood glucose levels, with an increase in cases attributed to factors such as inadequate nutrition, insufficient physical activity, hormonal imbalances, and obesity. In diabetes, albumin serves as a significant biomarker, instrumental in guiding insulin treatment, tracking glycemic management, assisting with diagnosis, and forecasting potential complications like diabetic ketoacidosis (DKA). Maintaining healthy albumin concentrations is vital for comprehensive diabetes management. For example, in January 2022, data from the National Library of Medicine, a US-based government library, indicated that in 2021, the global prevalence of diabetes stood at an estimated 10.5%, impacting around 536.6 million people between 20 and 79 years old. By the year 2045, this figure is forecast to climb to 12.2%, affecting approximately 783.2 million individuals. Consequently, the increasing occurrence of diabetes is projected to boost the growth of the albumin market in the coming years.

What Are The Segment Types Shaping The Albumin Market?

The albuminmarket covered in this report is segmented –

1) By Type: Human Serum Albumin; Bovine Serum Albumin; Recombinant Albumin

2) By Application: Therapeutics; Drug Formulation And Vaccines; Component Of Media; Other Applications

3) By Sales Channel: Business-To-Consumer (B2C); Business-To-Business (B2B)

4) By End-User: Hospitals And Clinics; Pharmaceutical And Biotechnology Companies; Research Institutes

Subsegments:

1) By Human Serum Albumin: Plasma-Derived Human Serum Albumin; Recombinant Human Serum Albumin; Human Serum Albumin For Therapeutic Use (In Liver Disease, Burns); Human Serum Albumin For Drug Delivery And Research Applications

2) By Bovine Serum Albumin: Bovine Serum Albumin For Laboratory Use (In Cell Culture); Bovine Serum Albumin For Diagnostic Kits; Bovine Serum Albumin As A Stabilizer In Vaccines And Biopharmaceuticals

3) By Recombinant Albumin: Recombinant Human Albumin For Therapeutic Applications; Recombinant Albumin For Biopharmaceutical Formulation; Recombinant Albumin For Cosmetic And Personal Care Applications; Recombinant Albumin For Research And Diagnostic Applications

How Are Trends Influencing The Albumin Market?

Major companies in the albumin market are actively creating innovative products, including recombinant albumin free from animal and human origins, to better serve customers with advanced functionalities. An animal- and human-origin-free recombinant albumin is defined as an albumin type produced using a non-mammalian expression system, such as yeast, and containing no components sourced from animals or humans. For instance, in March 2023, Albumedix, a UK-based manufacturer of recombinant human albumin (rHA), collaborated with Heartseed Inc., a Japan-based clinical-stage biotech company, to introduce Recombin. This critical excipient will be utilized in the production of Heartseed’s investigational cell therapy, HS-001, as its initial first-in-human clinical trial commences. This partnership marks a significant milestone in the progress of HS-001, which is poised to revolutionize the treatment of various diseases. The incorporation of recombination into the manufacturing process ensures the optimal performance and stability of the cell therapy, further strengthening its potential for therapeutic success.

Who Are The Top Performing Companies In The Albumin Market In Recent Years?

Major companies operating in the albumin market are Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Merck KGaA, Baxter International Inc., CSL Limited, Grifols SA, Mitsubishi Tanabe Pharma Corporation, Octapharma AG, Kedrion S.p.A., Biotest AG, Jiangxi Boya Bio-Pharmaceutical Co. Ltd., BPL (Bio Products Laboratory), Kamada Ltd., Proliant Biologicals, SeraCare Life Sciences Inc., HiMedia Laboratories, Albumedix Ltd., Medxbio Pte Ltd., Ventria Bioscience Inc., China Biologic Products Holdings Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/albumin-global-market-report

Which Geographies Are Emerging As Strong Markets For The Albumin Industry?

North America was the largest region in the albumin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the albumin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Albumin Market Report:

https://www.thebusinessresearchcompany.com/customise?id=16333&type=smp

Browse Through More Reports Similar to the Global Albumin Market 2025, By The Business Research Company

Stem Cell Assay Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cell-assay-global-market-report

Glycomics Or Glycobiology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

Hospital Capacity Management Solutions Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/hospital-capacity-management-solutions-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795